These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 27031503)
1. Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis. Gonzalez JV; Barboza AG; Vazquez FJ; Gándara E PLoS One; 2016; 11(3):e0151607. PubMed ID: 27031503 [TBL] [Abstract][Full Text] [Related]
2. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134 [TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257 [TBL] [Abstract][Full Text] [Related]
4. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445 [TBL] [Abstract][Full Text] [Related]
5. Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis. Vazquez F; Rodger M; Carrier M; Le Gal G; Reny JL; Sofi F; Mueller T; Nagpal S; Jetty P; Gandara E Eur J Vasc Endovasc Surg; 2015 Aug; 50(2):232-40. PubMed ID: 26092622 [TBL] [Abstract][Full Text] [Related]
6. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis. Qi X; Ren W; De Stefano V; Fan D Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1801-12.e7. PubMed ID: 24793031 [TBL] [Abstract][Full Text] [Related]
8. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Vayá A; Mira Y; Mateo J; Falco C; Villa P; Estelles A; Corella D; Fontcuberta J; Aznar J Thromb Haemost; 2003 Mar; 89(3):452-7. PubMed ID: 12624627 [TBL] [Abstract][Full Text] [Related]
9. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606 [TBL] [Abstract][Full Text] [Related]
10. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey. Ayyildiz O; Kalkanli S; Batun S; Aybak M; Isikdogan A; Tiftik N; Bolaman Z; Soker M; Muftuoglu E Heart Vessels; 2004 Jul; 19(4):164-6. PubMed ID: 15278388 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tsaousi C; Tzolou A; Kolaitis N; Vartholomatos G Int Angiol; 2003 Mar; 22(1):55-7. PubMed ID: 12771857 [TBL] [Abstract][Full Text] [Related]
12. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522 [TBL] [Abstract][Full Text] [Related]
13. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population. Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625 [TBL] [Abstract][Full Text] [Related]
14. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Barcellona D; Fenu L; Cauli C; Pisu G; Marongiu F Thromb Haemost; 2003 Dec; 90(6):1061-4. PubMed ID: 14652637 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke. Beye A; Pindur G Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458 [TBL] [Abstract][Full Text] [Related]
16. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
18. Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. Rodrigues CA; Rocha LK; Morelli VM; Franco RF; Lourenço DM J Thromb Haemost; 2004 Jul; 2(7):1211-2. PubMed ID: 15219221 [No Abstract] [Full Text] [Related]
19. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution. Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L; Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248 [TBL] [Abstract][Full Text] [Related]
20. Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis. Koshy A; Jeyakumari M Ann Hematol; 2006 Feb; 85(2):126-8. PubMed ID: 16283309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]